MedTrace Logo

Short Term Pancreatic Stenting Registry

NCT02262845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2017-03-21

No results posted yet for this study

Summary

The purpose of this study is to document clinical utility and distribution of indications for short term pancreatic stenting, and stent type preference by indication at tertiary referral centers with expertise in pancreatic endotherapy.

Conditions

  • Post-ERCP Acute Pancreatitis
  • Pancreatic Duct Stricture
  • Pancreatic Duct Stones
  • Pancreatic Duct Leakage

Interventions

DEVICE

The Advanix™ Pancreatic Stent and NaviFlex RX Pancreatic Delivery System and Pushers

Used to drain pancreatic ducts

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Paul Tarnasky, MD · The Methodist Hospital Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States
  • Germany
  • India
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262845 on ClinicalTrials.gov